Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Journal of Medical Virology|June 29, 2017
Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patientsHiromi Kan, Michio Imamura, Yoshiiku Kawakami, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 6, 2013
[A case of clonorchiasis complicated with the expansion of liver cyst]Yoko Kominami, Hiroshi Aikata, Ken Hiramatsu, et al.
Journal of Gastroenterology and Hepatology|November 20, 2015
Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort studyYuko Nagaoki, Hiroshi Aikata, Norihito Nakano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 5, 2013
Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseasesKeiichi Masaki, Shintaro Takaki, Hideyuki Hyogo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 27, 2016
Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis CKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.
Journal of Gastroenterology|July 26, 2017
Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver diseaseTakashi Nakahara, Hideyuki Hyogo, Atsushi Ono, et al.
Journal of Gastroenterology|November 9, 2016
ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis CKei Morio, Michio Imamura, Yoshiiku Kawakami, et al.
Plos One|August 11, 2017
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapyYuko Nagaoki, Michio Imamura, Hiroshi Aikata, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 28, 2015
Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case reportMasataka Tsuge, Akira Hiramatsu, Fumi Shinohara, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2020
Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive ProceduresYuno Nishida, Tomokazu Kawaoka, Michio Imamura, et al.
Pageof 7